RMC No. 42-2023: VAT-Exempt Medicines List Updated for FDA-Endorsed Products Under TRAIN and CREATE

RMC No. 42-2023 confirms FDA-endorsed updates to VAT-exempt medicines and applies exemption from FDA publication of the updated list. Pharmacies, hospitals, clinics, drug distributors, importers, and accounting teams dealing with medicines for cancer, diabetes, kidney disease, mental illness, tuberculosis, high cholesterol, and hypertension should immediately verify whether their products are covered by the FDA-endorsed updates […]

RMC No. 83-2022: Updated VAT-Exempt Medicines List for Diabetes, Hypertension, Mental Illness, Cancer, and Kidney Disease Drugs

RMC No. 83-2022 updates the VAT-exempt medicines list under CREATE, covering diabetes, hypertension, mental illness, cancer, and kidney disease drugs. Businesses that manufacture, import, distribute, sell, prescribe, dispense, procure, or account for medicines must immediately review their VAT treatment because RMC No. 83-2022 confirms updates to the List of VAT-Exempt Medicines under Republic Act No. […]